Letrozole, a non-steroidal aromatase inhibitor, is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By decreasing estrogen levels in the body, letrozole helps to slow or stop the growth of hormone-sensitive tumors. This article explores the effects and implications of letrozole use in cancer treatment.
Mechanism of Action
Letrozole works by inhibiting aromatase, an enzyme responsible for converting androgens to estrogens in the body. This action leads to:
- Reduced estrogen levels.
- Decreased tumor growth in estrogen-sensitive breast cancer.
Potential Benefits
The use of letrozole has several advantages for patients with hormone receptor-positive breast cancer:
- Improved survival rates compared to older treatments.
- Lower recurrence rates of breast cancer.
- Better management of estrogen levels, leading to reduced side effects compared to traditional estrogen therapies.
Side Effects
Like any medication, letrozole can have side effects. Common adverse effects include:
- Hot flashes
- Joint pain
- Fatigue
- Bone loss leading to osteoporosis
Conclusion
Letrozole has emerged as a pivotal medication in the fight against hormone receptor-positive breast cancer. Understanding its effects can help patients and healthcare providers make informed decisions regarding treatment strategies.